ASEAN KEY DESTINATIONS
During yesterday's seminar on prospects of the industry, Quang said he had told the Indian Business Chamber in Viet Nam (INCHAM) that Indian companies had provided drugs of high quality, safety and efficacy at reasonable prices in Viet Nam.
"The Ministry of Health recognises the efforts made by foreign investors in the development of the pharmaceutical sector and will try its best to create a favourable and equitable business environment for INCHAM members who invest in Viet Nam," Quang said.
The ministry is committed to continue increasing transparency and accountability, and will reform administrative procedures to smooth the way forward for enterprises, according to Quang. The ministry's goal is to develop the pharmaceutical sector on many levels, including investment, integration with the world market, and creation of new policies and laws governing the industry.
According to the ministry, 128 Indian enterprises among 545 foreign similar enterprises have been licensed to work in the pharmaceutical industry, accounting for 23.5 percent, the highest ranking.
The number of valid registrations granted to Indian drugs is 4507, accounting for 37.8 per cent, the highest level. Korean drugs (19.23 per cent) rank second.
India is an emerging pharmaceutical market in the Asia-Pacific region with a growth rate of 13 percent per year.
At US$193 million in export turnover to Viet Nam, India, the world's third-largest producer of pharmaceuticals, was the largest pharmaceutical exporter to Viet Nam in 2009.
Comment on this Article. Send them to firstname.lastname@example.org
Letters that do not contain full contact information cannot be published.
Letters become the property of AseanAffairs and may be republished in any format.
They typically run 150 words or less and may be edited
submit your comment in the box below